Arkadios Wealth Advisors Sarepta Therapeutics, Inc. Transaction History

Arkadios Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$77.28 - $99.42 $5,796 - $7,456	-75 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$72.25 - $168.95 $46,962 - $109,817	-650 Reduced 89.66%	75 $5,000
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $81,614 - $116,181	650 Added 866.67%	725 $123,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $5,739 - $10,168	75 New	75 $9,000

528

84M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.